25780462|t|Doxapram hastens the recovery following total intravenous anesthesia with dexmedetomidine, propofol and remifentanil.
25780462|a|Dexmedetomidine is a suitable sedative for awake fiberoptic intubation in patients with obstructive sleep apnea (OSA). However, previous studies have shown that dexmedetomidine delays recovery from propofol-remifentanil anesthesia. This study aimed to determine whether doxapram may hasten the recovery following dexmedotomidine-propofol-remifentanil anesthesia. Sixty patients scheduled for uvulopalatopharyngoplasty with total intravenous anesthesia were randomized to two groups according to the medicine given at the end of surgery. These were the doxapram (1 mg/kg) and control (normal saline) groups (n=30 per group). The primary outcome was the time to eye opening on verbal command. The time to return to spontaneous breathing, to hand squeezing in response to verbal command, to extubation of the trachea, and the heart rate (HR), bispectral index (BIS) values, respiratory rate (RR) and pulse oximetry values were also recorded and compared. The time to return to spontaneous breathing (5.2+-2.9 vs. 11.7+-3.4 min, P<0.001), eye opening (9.3+-4.7 vs. 15.9+-6.3 min, P<0.001), hand squeeze to command (11.8+-6.5 vs. 17.6+-7.7 min, P=0.0026) and extubation (14.2+-7.8 vs. 19.2+-9.6 min, P=0.0308) were significantly shorter in the doxapram group compared with the control group. BIS scores (at 3-14 min), RR (at 4-10 min) and HR (at 2-13 min) were significantly higher in the doxapram group compared with those in the control group (P<0.05). Doxapram hastens the recovery from dexmedetomidine-propofol-remifentanil anesthesia in patients undergoing uvulopalatopharyngoplasty, and may benefit patients with OSA.
25780462	0	8	Doxapram	Chemical	MESH:D004315
25780462	74	89	dexmedetomidine	Chemical	MESH:D020927
25780462	91	99	propofol	Chemical	MESH:D015742
25780462	104	116	remifentanil	Chemical	MESH:D000077208
25780462	118	133	Dexmedetomidine	Chemical	MESH:D020927
25780462	192	200	patients	Species	9606
25780462	206	229	obstructive sleep apnea	Disease	MESH:D020181
25780462	231	234	OSA	Disease	MESH:D020181
25780462	279	294	dexmedetomidine	Chemical	MESH:D020927
25780462	316	324	propofol	Chemical	MESH:D015742
25780462	325	337	remifentanil	Chemical	MESH:D000077208
25780462	388	396	doxapram	Chemical	MESH:D004315
25780462	431	446	dexmedotomidine	Chemical	-
25780462	447	455	propofol	Chemical	MESH:D015742
25780462	456	468	remifentanil	Chemical	MESH:D000077208
25780462	487	495	patients	Species	9606
25780462	670	678	doxapram	Chemical	MESH:D004315
25780462	1357	1365	doxapram	Chemical	MESH:D004315
25780462	1502	1510	doxapram	Chemical	MESH:D004315
25780462	1568	1576	Doxapram	Chemical	MESH:D004315
25780462	1603	1618	dexmedetomidine	Chemical	MESH:D020927
25780462	1619	1627	propofol	Chemical	MESH:D015742
25780462	1628	1640	remifentanil	Chemical	MESH:D000077208
25780462	1655	1663	patients	Species	9606
25780462	1718	1726	patients	Species	9606
25780462	1732	1735	OSA	Disease	MESH:D020181
25780462	Negative_Correlation	MESH:D004315	MESH:D020181
25780462	Negative_Correlation	MESH:D004315	MESH:D020927
25780462	Cotreatment	MESH:D000077208	MESH:D020927
25780462	Negative_Correlation	MESH:D000077208	MESH:D004315
25780462	Cotreatment	MESH:D015742	MESH:D020927
25780462	Negative_Correlation	MESH:D020927	MESH:D020181
25780462	Cotreatment	MESH:D000077208	MESH:D015742
25780462	Negative_Correlation	MESH:D004315	MESH:D015742

